This pipeline maps genes, with mutation or copy number alteration AND this alteration is highly correlated with mRNA expression, to pathways curated in the KEGG and BIOCARTA databases. It identifies pathways significantly enriched with these genes. The pipeline also identifies pathways significantly enriched with marker genes of each expression subtype of cancer.
genes with mutation: identified by the Mutation_Significance pipeline
genes with copy number alteration: identified by the CopyNumber_Gistic2 pipeline
correlation between copy number and mRNA expression: identified by the Correlate_CopyNumber_vs_mRNA pipeline
marker genes and expression subtypes: identified by the mRNAConsensusClustering pipeline
There are 250 genes with significant mutation (Q value <= 0.1) and 156 genes with significant copy number alteration (Q value <= 0.25). The identified marker genes (Q value <= 0.01 or within top 2000) are 2000 for subtype 1, 2000 for subtype 2, 2000 for subtype 3. Pathways significantly enriched with these genes (Q value <= 0.01) are identified :
17 pathways significantly enriched with genes with copy number alteration or mutation.
29 pathways significantly enriched with marker genes of gene expression subtype 1
62 pathways significantly enriched with marker genes of gene expression subtype 2
17 pathways significantly enriched with marker genes of gene expression subtype 3
Pathway | Nof Genes | Nof CNV_Mut | Enrichment | P value | Q value |
---|---|---|---|---|---|
BIOCARTA_CTCF_PATHWAY | 23 | 7 | 4 | 0 | 0 |
BIOCARTA_ARF_PATHWAY | 17 | 7 | 4.4 | 0 | 0 |
KEGG_PANCREATIC_CANCER | 70 | 10 | 2.9 | 0 | 0 |
KEGG_GLIOMA | 65 | 13 | 3.4 | 0 | 0 |
KEGG_PROSTATE_CANCER | 89 | 12 | 2.8 | 0 | 0 |
PIK3CG,TP53,PTEN,CDKN2A,MDM2,PIK3CA,PIK3R1
PIK3CG,TP53,RB1,CDKN2A,MDM2,PIK3CA,PIK3R1
CDKN2A,PIK3CA,AKT3,PIK3CG,EGFR,BRAF,TP53,RB1,CDK4,PIK3R1
PTEN,CDKN2A,PIK3CA,AKT3,PIK3CG,EGFR,BRAF,TP53,RB1,CDK4,PDGFRA,MDM2,PIK3R1
PTEN,PIK3CA,AKT3,PIK3CG,EGFR,BRAF,TP53,RB1,PDGFRA,MDM2,FGFR1,PIK3R1
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_PATHWAYS_IN_CANCER | 328 | 61 | 1 | 0 | 0 |
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 272 | 49 | 1 | 0 | 0.0001 |
KEGG_PARKINSONS_DISEASE | 130 | 26 | 1.4 | 0 | 0.0001 |
KEGG_TGF_BETA_SIGNALING_PATHWAY | 86 | 20 | 1.4 | 0 | 0.0014 |
KEGG_ALZHEIMERS_DISEASE | 167 | 29 | 1 | 0.0001 | 0.0025 |
HRAS,PGF,RXRA,CTNNA1,MECOM,CTNNA3,VEGFB,MAPK3,VEGFA,PDGFRB,BCL2L1,BMP4,BMP2,SMAD4,SMAD2,CBLC,LAMA4,ETS1,NTRK1,FGF5,CCNE2,CCNE1,CTBP2,FZD8,FZD2,STAT1,NRAS,RASSF1,PDGFB,PDGFA,WNT4,CDKN2B,FGFR2,WNT5A,GRB2,AXIN1,EPAS1,E2F1,E2F3,FASLG,AKT1,MAX,RHOA,CHUK,CYCS,CDK2,PRKCB,DAPK1,NCOA4,WNT11,GSTP1,CKS1B,WNT16,CDH1,TPM3,FIGF,COL4A2,COL4A1,FLT3,CBL,WNT2B
ADORA3,LPAR3,AGTR1,AGTR2,HTR1F,F2,PPYR1,GH1,CHRNB3,CHRNB2,CHRNG,TRPV1,EDNRA,NMUR1,PTGDR,AVPR2,MC3R,P2RY11,P2RY14,F2RL2,GRIK3,GALR3,GABRR2,GABRR1,GLP1R,ADORA2B,P2RY1,ADRA2A,GABRP,GABRD,GABRE,GABRA4,GABRA5,P2RX6,MTNR1B,ADRA1D,TACR1,CALCRL,PTGER1,PTGER3,FSHR,ADRB2,CHRM4,CALCR,PRSS1,TSHB,HRH4,PRLR,F2R
COX6C,COX7B,UBE2L3,VDAC1,UBA1,UQCRC2,ATP5E,UBE2G1,CYC1,UBE2G2,UCHL1,NDUFS6,NDUFS4,NDUFS2,CYCS,UBB,NDUFB7,ATP5G1,COX7A2L,ATP5G3,NDUFA8,NDUFA6,NDUFA7,NDUFA1,PARK7,SLC18A1
E2F4,ACVRL1,CDKN2B,RHOA,ROCK1,ACVR2A,AMH,MAPK3,TNF,COMP,PPP2CA,THBS2,BMP4,AMHR2,BMP2,SMAD7,SMAD4,SMAD2,PSG1,BMPR1A
PSENEN,COX6C,MAPK3,BACE1,COX7B,CACNA1F,UQCRC2,ATP5E,CYC1,NDUFS6,NDUFS4,PLCB4,NDUFS2,CYCS,PSEN2,ERN1,ADAM17,TNF,NDUFB7,PPP3R1,COX7A2L,ATP5G1,ATP5G3,CALML3,CHP,NDUFA8,NDUFA6,NDUFA7,NDUFA1
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_MAPK_SIGNALING_PATHWAY | 267 | 50 | 1 | 0 | 0 |
KEGG_PATHWAYS_IN_CANCER | 328 | 68 | 1.2 | 0 | 0 |
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 272 | 47 | 0.92 | 0 | 0.0001 |
KEGG_CELL_CYCLE | 128 | 28 | 1.3 | 0 | 0.0001 |
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 69 | 19 | 1.6 | 0 | 0.0001 |
MAP3K4,PLA2G1B,MAP2K5,MECOM,MAPK8,PLA2G2D,NTF3,MAP2K2,FGF5,FGF7,NFKB1,CACNG2,GADD45G,PLA2G3,GADD45B,MAP3K14,MAP3K12,MKNK2,PPP3CA,RASA1,RASA2,MAPK11,RPS6KA5,NRAS,DUSP2,RPS6KA2,MAPK14,DUSP9,FGF18,FGF17,TGFB3,TGFB1,PRKACB,FGF22,FGF20,NGF,FGFR4,MAPKAPK2,ELK4,EGF,CACNA1I,NR4A1,RAP1A,CACNA1H,CACNA1F,CACNA1C,PRKCB,MAP3K1,CDC25B,CRK
STAT5B,CTNNB1,RARB,MECOM,CTNNA3,CTNNA2,VEGFB,JUP,PIAS3,VEGFA,MAPK8,BCL2L1,DVL2,MAP2K2,CREBBP,SMAD3,SMAD2,CBLC,ETS1,FGF5,FGF7,NFKB1,FLT3LG,CTBP1,CTBP2,ZBTB16,FZD1,BIRC5,FZD4,NRAS,ARAF,TCEB1,WNT7A,FGF18,MMP9,FGF17,TGFB3,MMP2,TGFB1,WNT4,CDKN2B,RALA,FGF22,FGF20,ARNT,ITGAV,EGF,RUNX1,TRAF4,ITGA2,CDKN1A,CDKN1B,MTOR,ABL1,E2F1,PAX8,RUNX1T1,DAPK2,DAPK3,PRKCB,WNT11,EGLN2,CDH1,TCF7L1,IGF1R,COL4A2,BAX,CRK
CGA,ADORA3,LPAR3,CHRNA9,MC1R,LTB4R,S1PR4,CHRNA6,CHRNA1,HTR1F,SSTR5,SSTR1,F2,CHRNB3,MCHR1,GLRA3,EDNRA,MC5R,GRM1,GRM8,NPY2R,GRIA2,P2RY14,MC4R,HTR2C,F2RL2,TSPO,THRA,GABRB1,PTGIR,NTSR1,GABRR1,DRD1,DRD5,CNR1,P2RY2,GABRP,GRIN1,P2RX4,GPR35,PTGER2,PTGER3,CHRM4,CTSG,PRSS1,NR3C1,HRH3
TGFB3,PKMYT1,TTK,TGFB1,CDKN2B,CCNA2,ANAPC1,ANAPC2,CHEK1,CREBBP,SMAD3,SMAD2,CDKN1A,CDKN1B,ABL1,E2F1,CDC2,MCM5,MCM6,GADD45G,BUB1B,GADD45B,BUB1,CDC25C,YWHAE,CDC25A,CDC25B,ORC3L
MASP1,SERPINA5,CFI,F12,F10,F8,F7,C8G,SERPINF2,CNTN1,F2,TFPI,C3,C1S,FGA,FGB,CR2,C4BPB,SERPIND1
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_PURINE_METABOLISM | 158 | 35 | 1.3 | 0 | 0.0001 |
KEGG_CELL_CYCLE | 128 | 27 | 1.2 | 0 | 0.0012 |
KEGG_CITRATE_CYCLE_TCA_CYCLE | 32 | 11 | 2 | 0 | 0.0015 |
KEGG_PYRIMIDINE_METABOLISM | 98 | 22 | 1.3 | 0 | 0.0015 |
KEGG_CALCIUM_SIGNALING_PATHWAY | 178 | 33 | 1 | 0 | 0.0015 |
SLC25A16,ADCY8,NT5C2,POLE,NME5,PDE5A,ADSS,PPAT,POLE3,ENTPD5,ENTPD4,ENTPD1,ALLC,AK1,POLDIP2,PDE7B,PDE11A,GUCY1A3,IMPDH1,NT5C,POLR1D,POLR1B,ADK,POLR2K,POLA1,DCK,POLA2,POLR2D,PFAS,POLR3F,NPR2,PDE3A,AMPD3,POLR3D,ITPA
DBF4,CDKN2A,CDKN2D,CCNA1,CCNA2,STAG2,CUL1,ANAPC1,ANAPC2,RBL2,ESPL1,ORC1L,EP300,RBX1,TFDP2,TFDP1,CREBBP,E2F1,MAD1L1,CDC45L,CDK6,CCND2,BUB1B,ORC2L,YWHAB,CDC25C,YWHAH
PDHB,IDH3G,IDH1,PDHA1,SUCLA2,FH,IDH3A,SDHC,SDHD,KRT17,MDH1
NT5C2,POLE,NME5,CTPS2,CMPK1,POLE3,ENTPD5,CDA,ENTPD4,ENTPD1,POLDIP2,NT5C,POLR1D,POLR1B,POLR2K,POLA1,DCK,POLA2,POLR2D,POLR3F,POLR3D,ITPA
ADCY8,ITPKB,ATP2B1,AGTR1,ATP2B3,GRIN2C,PRKACA,BST1,NTSR1,PHKA2,ADORA2B,BDKRB1,SPHK1,VDAC2,VDAC3,VDAC1,ATP2A2,ATP2A3,TBXA2R,CACNA1G,ADRA1D,EDNRB,PLCB3,PLCB2,PRKCA,GRM1,PTAFR,PPP3R1,PTK2B,CHP,CAMK2A,PTGFR,HTR2C
Let genes with copy number alteration or mutation be query genes. Let marker genes of specific identified subtypes be query genes. The Enrichment is calculated as:
-
Enrichment = log2 (# of query genes in the pathway/# No of query genes) - log2 (# of genes in the pathway/# of human genes)
The statistical signficance of the pathways that are enriched with genes with copy number alteration or mutation, and the pathways that are enriched with markers genes of specific identified subtypes is measured by P value.
-
P value = Fisher exact P value
The Q value is for adjusting P value for multiple testing. A public available R package is used to calculate the Q value.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.